218 related articles for article (PubMed ID: 22007511)
1. [Advances in parallel artificial membrane permeability assay and its applications].
Wu YF; Liu H; Ni JM
Yao Xue Xue Bao; 2011 Aug; 46(8):890-5. PubMed ID: 22007511
[TBL] [Abstract][Full Text] [Related]
2. High throughput artificial membrane permeability assay for blood-brain barrier.
Di L; Kerns EH; Fan K; McConnell OJ; Carter GT
Eur J Med Chem; 2003 Mar; 38(3):223-32. PubMed ID: 12667689
[TBL] [Abstract][Full Text] [Related]
3. Artificial membrane assays to assess permeability.
Faller B
Curr Drug Metab; 2008 Nov; 9(9):886-92. PubMed ID: 18991585
[TBL] [Abstract][Full Text] [Related]
4. Skin-PAMPA: a new method for fast prediction of skin penetration.
Sinkó B; Garrigues TM; Balogh GT; Nagy ZK; Tsinman O; Avdeef A; Takács-Novák K
Eur J Pharm Sci; 2012 Apr; 45(5):698-707. PubMed ID: 22326705
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of in vitro brain penetration: optimized PAMPA and MDCKII-MDR1 assay comparison.
Carrara S; Reali V; Misiano P; Dondio G; Bigogno C
Int J Pharm; 2007 Dec; 345(1-2):125-33. PubMed ID: 17624703
[TBL] [Abstract][Full Text] [Related]
7. The rise of PAMPA.
Avdeef A
Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):325-42. PubMed ID: 16922646
[TBL] [Abstract][Full Text] [Related]
8. Drug permeability profiling using cell-free permeation tools: Overview and applications.
Berben P; Bauer-Brandl A; Brandl M; Faller B; Flaten GE; Jacobsen AC; Brouwers J; Augustijns P
Eur J Pharm Sci; 2018 Jul; 119():219-233. PubMed ID: 29660464
[TBL] [Abstract][Full Text] [Related]
9. Predicting both passive intestinal absorption and the dissociation constant toward albumin using the PAMPA technique.
Bujard A; Sol M; Carrupt PA; Martel S
Eur J Pharm Sci; 2014 Oct; 63():36-44. PubMed ID: 25008117
[TBL] [Abstract][Full Text] [Related]
10. A new PAMPA model using an in-house brain lipid extract for screening the blood-brain barrier permeability of drug candidates.
Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
Int J Pharm; 2016 Mar; 501(1-2):102-11. PubMed ID: 26836708
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
[TBL] [Abstract][Full Text] [Related]
12. pH-permeability profiles for drug substances: Experimental detection, comparison with human intestinal absorption and modelling.
Oja M; Maran U
Eur J Pharm Sci; 2018 Oct; 123():429-440. PubMed ID: 30100533
[TBL] [Abstract][Full Text] [Related]
13. Prediction of the Passive Intestinal Absorption of Medicinal Plant Extract Constituents with the Parallel Artificial Membrane Permeability Assay (PAMPA).
Petit C; Bujard A; Skalicka-Woźniak K; Cretton S; Houriet J; Christen P; Carrupt PA; Wolfender JL
Planta Med; 2016 Mar; 82(5):424-31. PubMed ID: 26872320
[TBL] [Abstract][Full Text] [Related]
14. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
[TBL] [Abstract][Full Text] [Related]
15. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
Akamatsu M; Fujikawa M; Nakao K; Shimizu R
Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
[TBL] [Abstract][Full Text] [Related]
16. PAMPA--a drug absorption in vitro model 11. Matching the in vivo unstirred water layer thickness by individual-well stirring in microtitre plates.
Avdeef A; Nielsen PE; Tsinman O
Eur J Pharm Sci; 2004 Aug; 22(5):365-74. PubMed ID: 15265506
[TBL] [Abstract][Full Text] [Related]
17. A PAMPA study of the permeability-enhancing effect of new ceramide analogues.
Sinkó B; Kökösi J; Avdeef A; Takács-Novák K
Chem Biodivers; 2009 Nov; 6(11):1867-74. PubMed ID: 19937821
[TBL] [Abstract][Full Text] [Related]
18. [In vitro methods of transdermal drug absorption: the skin PAMPA model].
Sinkó B; Takácsné Novák K
Acta Pharm Hung; 2012; 82(4):127-36. PubMed ID: 23444720
[TBL] [Abstract][Full Text] [Related]
19. Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.
Vucicevic J; Nikolic K; Dobričić V; Agbaba D
Eur J Pharm Sci; 2015 Feb; 68():94-105. PubMed ID: 25542610
[TBL] [Abstract][Full Text] [Related]
20. The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
Tam KY; Avdeef A; Tsinman O; Sun N
J Med Chem; 2010 Jan; 53(1):392-401. PubMed ID: 19947605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
